Title: Vitamins China Monthly Report – July 2026 Commentary
Source: CCM
Company dynamics
- On 1 July, 2026, Tianxin Pharma announced that it would carry out a summer maintenance shutdown lasting approximately eight weeks.
- On 14 July, 2026, Brother Enterprises released its semi-annual performance forecast for 2026.
- On 15 July, 2026, Adisseo and Guangji Pharma released their semi‑annual performance reports for 2026.
Project progress
- In late June 2026, Weishi Bio's 8,000 t/a vitamins project passed acceptance check.
- On 29 June, 2026, the EI report for Lier Biotech's bio-fermentation technology industrial construction project (Phase II modification) was publicised.
- On 30 June, 2026, the EI report for Jiangxi Henley Yuan's 10,000 t/a sports nutrition food project was approved.
- On 2 July, 2026, the EI report for Kexing Pharma's 12,000 t/a animal health products production line project was accepted.
The USD/RMB exchange rate in this Report is USD1.00=CNY6.8067 on 1 July, 2026, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.
Please purchase to view
Add to cart
